30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

RTI Surgical Reports 1Q19 Orthopedic Revenue of $60MM, +0.2% vs. 1Q18 -

By Mike Evers, ORTHOWORLD

RTI Surgical posted 1Q19 orthopedic revenue of USD $60MM, +0.2% vs 1Q18.

  • Completed the acquisition of Paradigm Spine
  • Focusing on accelerated reimbursement, physician engagement and salesforce execution to drive sales of coflex Interlaminar Stabilization device acquired from Paradigm
  • Restructured and expanded commercial team
  • 2019 guidance for all revenue in the range of $325MM to $335MM, +15% to +19% growth compared to 2018

 

Estimated segment sales and growth on an as-reported basis are as follows ($MM).

  1Q19 1Q18 $ Chg % Chg
Spine $24.1 $23.4 $0.7 3.0%
Orthobiologics $35.9 $36.5 -$0.6 -1.7%
Total $60.0 $59.9 $0.1 0.2%

Revenue by geographic region is as follows ($MM).

Geographic Region 1Q19 1Q18 $ Chg % Chg
US $54.0 $53.8 $0.2 0.3%
Ex-US $6.0 $6.1 -$0.1 -1.1%
Total $60.0 $59.9 $0.1 0.2%

Net earnings, inclusive of all revenue, are as follows.

1Q19 Amount ($MM) % of Sales
Sales $69.7  
   Cost of Sales -$31.7 45.5%
   Selling and Admin -$31.9 45.7%
   R & D -$4.3 6.2%
   Other -$10.9 15.6%
Net Earnings -$9.1 -13.0%

 

Source: RTI Surgical; ORTHOWORLD estimates.

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.